We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+4.51%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$369M
AUM Growth
-$418K
Cap. Flow
-$12.4M
Cap. Flow %
-3.37%
Top 10 Hldgs %
23.09%
Holding
244
New
26
Increased
87
Reduced
73
Closed
45

Top Buys

Rank Stock Value
1
MO icon
Altria Group
MO
+$3.02M
2
PFE icon
Pfizer
PFE
+$3M
3
CVS icon
CVS Health
CVS
+$2.72M
4
KHC icon
Kraft Heinz
KHC
+$2.68M
5
EXC icon
Exelon
EXC
+$2.67M

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$3.8M
2
FUN icon
Cedar Fair
FUN
+$2.55M
3
AZN icon
AstraZeneca
AZN
+$2.41M
4
GSK icon
GSK
GSK
+$2.38M
5
PPL
PPL Corp
PPL
+$2.23M

Sector Composition

Rank Sector Weight
1 Technology 14.63%
2 Healthcare 14.59%
3 Consumer Staples 11.98%
4 Industrials 10.74%
5 Utilities 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WY icon
176
Weyerhaeuser
WY
$17.3B
$412K 0.11%
+12,310
New +$414K
IJR icon
177
iShares Core S&P Small-Cap ETF
IJR
$109B
$398K 0.11%
5,681
-4
-0.1% -$277
BFX
178
DELISTED
BowFlex Inc.
BFX
$359K 0.1%
18,770
+1,753
+10% +$31.7K
CVX icon
179
Chevron
CVX
$378B
$347K 0.09%
3,328
-135
-4% -$14.3K
TREC
180
DELISTED
Trecora Resources
TREC
$346K 0.09%
30,770
+1,957
+7% +$21.9K
MSFT icon
181
Microsoft
MSFT
$2.99T
$342K 0.09%
4,963
-271
-5% -$18.6K
PPL
182
PPL Corp
PPL
$26.7B
$328K 0.09%
8,492
-57,690
-87% -$2.23M
XOM icon
183
ExxonMobil
XOM
$615B
$318K 0.09%
3,941
-16
-0.4% -$1.31K
AUTO
184
DELISTED
AutoWeb, Inc. Common Stock
AUTO
$305K 0.08%
24,199
+3,073
+15% +$39.1K
MAGN
185
Magnera Corp
MAGN
$481M
$300K 0.08%
1,181
+248
+27% +$63.1K
CCL icon
186
Carnival Corporation Ltd
CCL
$35.7B
$270K 0.07%
4,123
+475
+13% +$29.6K
SXT icon
187
Sensient Technologies
SXT
$4.67B
$270K 0.07%
3,357
– –
OXM icon
188
Oxford Industries
OXM
$608M
$269K 0.07%
+4,298
New +$248K
TDAY
189
USA Today Co
TDAY
$1.24B
$249K 0.07%
18,444
-72,951
-80% -$974K
IART icon
190
Integra LifeSciences
IART
$1.47B
$218K 0.06%
+4,000
New +$191K
MFC icon
191
Manulife Financial
MFC
$70.6B
$217K 0.06%
11,542
– –
COP icon
192
ConocoPhillips
COP
$141B
$207K 0.06%
4,703
– –
ARCC icon
193
Ares Capital
ARCC
$13.6B
$171K 0.05%
10,449
– –
DDC
194
DELISTED
Dominion Diamond Corporation
DDC
$143K 0.04%
11,418
– –
FLG
195
Flagstar Bank National Association
FLG
$6.19B
$139K 0.04%
3,533
– –
DMF
196
DELISTED
BNY Mellon Municipal Income
DMF
$93K 0.03%
10,372
– –
AKAM icon
197
Akamai
AKAM
$17.9B
– –
-35,618
Closed -$2.13M
AZN icon
198
AstraZeneca
AZN
$255B
– –
-38,641
Closed -$2.41M
BAC icon
199
Bank of America
BAC
$424B
– –
-9,600
Closed -$226K
BBWI icon
200
Bath & Body Works
BBWI
$4.13B
– –
-24,447
Closed -$931K
6 7
8
9 10

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
TFM
TFC Financial Management Boston, Massachusetts $812M AUM 17.34% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return

Stanley-Laman Group's Q2 2017 Portfolio in Review

As of Q2 2017, Stanley-Laman Group held 244 positions worth $369M, down 0.11% from $369M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Stanley-Laman Group withdrew a net $12.4M in Q2 2017, closing 45 positions and reducing 73 holdings. Its most notable exit was Cedar Fair, an estimated $2.55M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Stanley-Laman Group opened a new position in Altria Group worth $3.07M.

  • Stanley-Laman Group's largest Q2 2017 buy was Altria Group: 41,225 shares worth $3.07M.
  • Stanley-Laman Group added most to Pfizer in Q2 2017, an estimated $3M increase.
  • Stanley-Laman Group's biggest Q2 2017 reduction was Monsanto Co, cutting an estimated $3.8M.
  • Stanley-Laman Group fully exited Cedar Fair in Q2 2017, selling an estimated $2.55M.
  • Stanley-Laman Group's ten largest holdings make up 23% of its $369M portfolio in Q2 2017.
  • Stanley-Laman Group opened 26 new positions and closed 45 in Q2 2017.
  • Stanley-Laman Group's portfolio value fell 0.11% quarter-over-quarter to $369M.

Based on Stanley-Laman Group's 13F filing for Q2 2017, filed 7 Aug 2017.